Vemurafenib is a Promising Treatment for Skin Cancer
by Maejoy Tutor in Beauty & Wellness on Aug 28, 2011
A latest cancer drug that was tested in the area of Tampa Bay gives optimism to several patients having the deadliest type of skin cancer.
The Food and Drug Administration has approved the pill Vemurafenib just last week. The pill will be sold under the name Zelboraf by Roche. The researchers are supposing that this drug can aim at a definite gene, which is found in tumors of skin cancer.
According to the director of the Donald A. Adam Comprehensive Melanoma Research Center at the H. Lee Moffitt Cancer Center, Jeffrey Weber, this study is the first within the series of drugs that are targeted; this means that it is a drug that aims at a particular mutation within just half of all of the melanomas that start on the skin. In addition, he expressed that this is really significant since it is the prototype or the very first in a group of oral drugs.
Weber further added that they have patients who really appeared like they have been at the door of death. However, after the patients tool the drug, just two weeks later, the patients have felt healthier.
The approval of the drug was based on the researchers study on 675 patients. The patients have taken in either a chemotherapy drug or Zelboraf.
The study’s results found out that 77% of the patients who took Zelboraf are still living and those who took the older drug shows 64%.
However, the drug accounted that the drug is not effective for everyone.
Related Posts:
